3[10]Cunha BA.Pseudomonas aeruginosa:resistance and therapy[J].Semin Respir Infect,2002,17(3):231 239.
4乔静贤，抗感染与化疗杂志，1997年，3卷，125页
5申正义，抗感染与化疗杂志，1997年，3卷，125页
6周贵民，中华微生物学和免疫学杂志，1995年，15卷，219页
7Bustamante CI, Wharton RC, Wade JC. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolate of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,1990,34(9):1814-1815.
8Dudley M N, Blaser J, Gilber D, et al. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa : effect of simultaneous versus staggered administration in an in vitro model of infection[J]. J Infect Dis, 1991,164(3):499-506.
9Klepser ME, Patel KB, Nicolau DP, et al. Comparison of bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 19
